Reason: Filed for bankruptcy
Last recorded trade on: October 20, 2023
Source: https://www.reuters.com/business/biotech-firm-amyris-files-bankruptcy-us-2023-08-10/
P/E ratio for Amyris (AMRS)
P/E ratio on October 20, 2023 (TTM): -0.0273
According to Amyris's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.0273224. At the end of 2022 the company had a P/E ratio of -0.9329.
P/E ratio history for Amyris from 2010 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -0.9329 | -82.76% |
| 2021 | -5.41 | 68.95% |
| 2020 | -3.20 | 189.12% |
| 2019 | -1.11 | 19.04% |
| 2018 | -0.9304 | -8.7% |
| 2017 | -1.02 | -51.14% |
| 2016 | -2.09 | 161.36% |
| 2015 | -0.7980 | -101.16% |
| 2014 | 68.7 | -4123.95% |
| 2013 | -1.71 | 105.1% |
| 2012 | -0.8320 | -71.23% |
| 2011 | -2.89 | 112.85% |
| 2010 | -1.36 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 | -8.46 | 30,846.77% | 🇺🇸 USA |
 | 2.10 | -7,774.91% | 🇺🇸 USA |
 | 4.38 | -16,121.18% | 🇺🇸 USA |
 | -1.69 | 6,077.20% | 🇺🇸 USA |
 | -2.53 | 9,176.82% | 🇺🇸 USA |
 | 6.26 | -23,019.40% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.